Biogen Inc
DUS:IDP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biogen Inc
DUS:IDP
|
US |
|
A
|
Asahi Intecc Co Ltd
F:6XT
|
JP |
|
D
|
Deutsche Post AG
XMUN:DPWA
|
DE |
|
3
|
3M Co
F:MMM
|
US |
|
MagnaChip Semiconductor Corp
NYSE:MX
|
LU |
|
U
|
Ulta Beauty Inc
XMUN:34U
|
US |
|
Philip Morris International Inc
NYSE:PM
|
US |
|
P
|
PetroChina Co Ltd
SWB:PC6
|
CN |
|
C
|
Carlisle Companies Inc
F:CLE
|
US |
|
Tempest Therapeutics Inc
F:3OS
|
US |
|
Full Truck Alliance Co Ltd
F:892
|
CN |
|
P
|
Pacific Biosciences of California Inc
F:P09
|
US |
|
P
|
Pan American Silver Corp
XMUN:PA2
|
CA |
|
C
|
Coca-Cola Europacific Partners PLC
XMUN:CK0
|
UK |
|
City Holding Co
NASDAQ:CHCO
|
US |
|
H
|
Henry Schein Inc
SWB:HS2
|
US |
|
K
|
Kering SA
F:PPX
|
FR |
|
S
|
Societe Generale SA
BMV:GLEN
|
FR |
|
A
|
Annaly Capital Management Inc
F:AAY
|
US |
|
Fastly Inc
NYSE:FSLY
|
US |
Bankruptcy Probability
Biogen Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Biogen Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Biogen Inc
NASDAQ:BIIB
|
28.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
162.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
377.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
178.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
66.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
42.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Biogen Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Biogen Inc has total debt of 6.3B USD. This includes both short-term (0 USD) and long-term (6.3B USD) debt.
You can find a full breakdown on its Balance Sheet.
